Literature DB >> 9932828

Successful treatment of widely disseminated acanthamoebiasis.

S Oliva1, M Jantz, R Tiernan, D L Cook, M A Judson.   

Abstract

Disseminated Acanthamoeba infections are almost invariably fatal, with no universally accepted standard for treatment. Reports of acanthamoebiasis in non-human-immunodeficiency-virus infected hosts are rare. We successfully treated a lung transplant patient who had disseminated acanthamoebiasis using a combination of pentamidine, 5-fluorocytosine, itraconazole, and topical chlorhexidine gluconate/ketoconazole cream.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9932828     DOI: 10.1097/00007611-199901000-00010

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  9 in total

Review 1.  Disseminated Acanthamoeba infection in a heart transplant recipient treated successfully with a miltefosine-containing regimen: Case report and review of the literature.

Authors:  Max N Brondfield; Michael J A Reid; Rachel L Rutishauser; Jennifer R Cope; Jevon Tang; Jana M Ritter; Almea Matanock; Ibne Ali; Sarah B Doernberg; Alexandra Hilts-Horeczko; Teresa DeMarco; Liviu Klein; Jennifer M Babik
Journal:  Transpl Infect Dis       Date:  2017-03-06       Impact factor: 2.228

2.  Inability to make a premortem diagnosis of Acanthamoeba species infection in a patient with fatal granulomatous amebic encephalitis.

Authors:  Karen C Bloch; Frederick L Schuster
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

Review 3.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

4.  Enucleation following treatment with intravenous pentamidine for Acanthamoeba sclerokeratitis.

Authors:  Rebecca A Kuennen; Reynell Harder Smith; Thomas F Mauger; Elson Craig
Journal:  Clin Ophthalmol       Date:  2010-10-05

Review 5.  Acanthamoeba spp. as agents of disease in humans.

Authors:  Francine Marciano-Cabral; Guy Cabral
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

Review 6.  CYP51 as drug targets for fungi and protozoan parasites: past, present and future.

Authors:  Galina I Lepesheva; Laura Friggeri; Michael R Waterman
Journal:  Parasitology       Date:  2018-04-12       Impact factor: 3.234

Review 7.  Solid Organ Transplant and Parasitic Diseases: A Review of the Clinical Cases in the Last Two Decades.

Authors:  Silvia Fabiani; Simona Fortunato; Fabrizio Bruschi
Journal:  Pathogens       Date:  2018-07-31

Review 8.  Paradigms of Protist/Bacteria Symbioses Affecting Human Health: Acanthamoeba species and Trichomonas vaginalis.

Authors:  Fiona L Henriquez; Ronnie Mooney; Timothy Bandel; Elisa Giammarini; Mohammed Zeroual; Pier Luigi Fiori; Valentina Margarita; Paola Rappelli; Daniele Dessì
Journal:  Front Microbiol       Date:  2021-01-07       Impact factor: 5.640

9.  Molecular identification and genotyping of Acanthamoeba spp., in bronchoalveolar lavage fluid from immunocompetent patients with chronic respiratory disorders (CRD).

Authors:  Reza Saberi; Maryam Nakhaei; Mahdi Fakhar; Hossein Zarrinfar; Ali Sharifpour; Hajar Ziaei Hezarjaribi
Journal:  Parasitol Res       Date:  2022-08-05       Impact factor: 2.383

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.